Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03854344 · ClinicalTrials.gov registry record · Phase 4

Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain

A Phase 4 study of Pain, Postoperative and Burns, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
Phase 4
Development phase
75
Enrollment target
1
Study location

NCT03854344 is a Phase 4 study of Pain, Postoperative and Burns that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 75 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03854344, a Phase 4 study of Pain, Postoperative and Burns, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness burn wounds.

Interventions

  • DRUG Liposomal bupivacaine
  • DRUG Bupivacaine Hydrochloride
  • DRUG Lidocaine Hydrochloride

Study Locations (1)

Kansas

  • The University of Kansas Health System - Kansas City

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2019-03-18
Est. Completion 2025-12-31
Phase Phase 4

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT03854344

The ClinicalTrials.gov registry entry for NCT03854344 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (72% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 3 interventions - of which Liposomal bupivacaine is the first listed.

NCT03854344 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT03854344 about?

NCT03854344 is a clinical study titled "Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain". Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness burn w...

What is the current status of trial NCT03854344?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2019-03-18. Estimated completion is 2025-12-31.

What conditions does trial NCT03854344 study?

This clinical trial studies the following conditions: Pain, Postoperative, Burns.

What interventions are being tested in trial NCT03854344?

The interventions under investigation include: Liposomal bupivacaine (DRUG), Bupivacaine Hydrochloride (DRUG), Lidocaine Hydrochloride (DRUG).

Who is sponsoring clinical trial NCT03854344?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03854344 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.